Skip to content

Virtual Reality for Urological Procedures

Feasibility of a Virtual Reality Intervention for Patients Undergoing Urological Procedures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06534086
Enrollment
100
Registered
2024-08-02
Start date
2024-06-06
Completion date
2024-11-01
Last updated
2025-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety State, Feasibility, Pain, Satisfaction, Patient

Keywords

feasibility, virtual reality, perioperative mental health

Brief summary

It is standard practice for most cystoscopies and vasectomies in an office or outpatient setting to be performed under local anesthesia while the patient is awake and conscious. However, given the conscious nature of these procedures, patients may experience anxiety-inducing stressors that they otherwise would not under general anesthesia. Stressors such as hearing surgical terminology, technical discussion, and injection of local anesthetic have been previously documented as sources of perioperative anxiety and pain in awake surgeries. The current study will examine the feasibility and pilot outcomes of Virtual Reality (VR) guided meditation therapy during cystoscopies and vasectomies. Feasibility will be examined through: (1) recruitment capability and resulting sample characteristics, (2) data collection procedures (including randomization) and outcome measures, and (3) participant acceptability and suitability of the VR intervention during the procedures. The investigators will also evaluate pilot outcomes of the VR intervention on pain, anxiety, and overall satisfaction with the procedure. Results of this study will inform the development of a large-scale randomized clinical trial (RCT) to evaluate the efficacy of this intervention. Participants will be asked to complete questionnaires before and after their procedure and will be asked for a verbal measure of their pain and anxiety during the procedure.

Interventions

Tripp application on Meta Quest 3 VR headset

OTHERTreatment as usual

No VR, local anesthetic only

Sponsors

University of Manitoba
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

Other = feasibility (primary) + clinical pilot outcomes (secondary)

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years of age or older * can speak and read English * have an indication for a cystoscopy or elected for a vasectomy * are scheduled to undergo their respective procedure under local anesthesia at the Men's Health Clinic between the dates of May-November 2024.

Exclusion criteria

* those who are not competent to provide informed consent (e.g., due to cognitive impairment) * those who are unable to participate in a VR intervention (e.g., due to visual or auditory impairment)

Design outcomes

Primary

MeasureTime frameDescription
Impressions of the VR based on open-ended responses on the Virtual Reality Impression ScaleImmediate post-operativeNegative and positive impressions of the VR intervention (open ended/qualitative)
Recruitment ratethrough study completion, up to 1 yearProportion of individuals who consent to participation and the number of recruited participants per week
Inclusion criteria and demographic and surgery-related differencesthrough study completion, up to 1 yearProportion of individuals who meet inclusion criteria and any demographic and surgery-related differences in potentially eligible participants
Retention of participants in the studyImmediate post-operativeProportion of individuals who tolerate the intervention and complete the study
Acceptability through elevate scores on the Virtual Reality Impression ScaleImmediate post-operativeAcceptability of the VR program during urological procedures (0 thru 100, 100=positive impressions)

Secondary

MeasureTime frameDescription
State Trait Anxiety Inventory (STAI) elevated scoresPre-operative, acute post-operative (immediately following surgery)Brief self-report questionnaire with questions surrounding anxiety traits (0 thru 63, higher score=more severe anxiety)
PROMIS Pain Intensity Scale total scoreAcute post-operative (immediately following surgery)Brief self-report questionnaire with questions surrounding experienced pain (3 thru 15, 15=greater pain severity)
Satisfaction With Surgery scoreAcute post-operative (immediately following surgery)Item to assess overall satisfaction with surgery (0 thru 10, 10=greater satisfaction)
Subjective assessment of time spent in VR vs. actual time in VREvaluated immediate post-operativePerception of time during procedure compared to actual time among those in VR
i-Group Presence Questionnaire (IPQ) scoreAcute post-operative (immediately following surgery)Brief self-report questionnaire with questions surrounding VR experience (spatial presence, involvement, experience realism), higher scores=greater presence
Selection of VR experiencePre-operativeWhat Tripp experience that participants select (out of 5 potential programs)
Scores on the National Comprehensive Cancer Network (NCCN) Distress Thermometer (and adapted Anxiety Thermometer)Pre-operative, acute post-operative (immediately following surgery)Brief self-report visual analogue scales (VAS) for anxiety/distress (0 thru 10, 10=worse anxiety/distress)
Visual Analogue Scale pain severityPeri-operative (mid-way through procedure)Brief self-report visual analogue scales (VAS) for acute pain (o thru 10, 10=more severe pain)
Visual Analogue Scale anxiety severityPeri-operative (mid-way through procedure)Brief self-report visual analogue scales (VAS) for acute anxiety (0 thru 10, 10=more severe anxiety)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026